Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kamper

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Pathology. Clinical Research|July 24, 2025
Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphomaMaja Dam Andersen, Katharina Wolter, Marie Hairing Enemark, et al.
European Journal of Haematology|October 12, 2024
Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal InvolvementMaja Dam Andersen, Katharina Wolter, Marie Beck Hairing Enemark, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Leukemia & Lymphoma|December 21, 2013
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvementTarec Christoffer El-Galaly, Martin Hutchings, Karen Juul Mylam, et al.
Blood Advances|April 1, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphomaNinja Övergaard, Kjersti Lia, Jeremia Collin, et al.
British Journal of Haematology|June 13, 2024
Long-term cause-specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens-A nationwide Danish cohort studySára Rossetti, Sidsel Jacobsen Juul, Frank Eriksson, et al.
American Journal of Hematology|April 18, 2026
Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched ComparatorsSissel Johanne Godtfredsen, Joachim Baech, Mikkel Porsborg Andersen, et al.
British Journal of Haematology|April 30, 2024
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort studyJulie Haugaard Vandtved, Andreas Kiesbye Øvlisen, Joachim Baech, et al.
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Pathology. Clinical Research|July 24, 2025
Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphomaMaja Dam Andersen, Katharina Wolter, Marie Hairing Enemark, et al.
European Journal of Haematology|October 12, 2024
Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal InvolvementMaja Dam Andersen, Katharina Wolter, Marie Beck Hairing Enemark, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Leukemia & Lymphoma|December 21, 2013
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvementTarec Christoffer El-Galaly, Martin Hutchings, Karen Juul Mylam, et al.
Blood Advances|April 1, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphomaNinja Övergaard, Kjersti Lia, Jeremia Collin, et al.
British Journal of Haematology|June 13, 2024
Long-term cause-specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens-A nationwide Danish cohort studySára Rossetti, Sidsel Jacobsen Juul, Frank Eriksson, et al.
American Journal of Hematology|April 18, 2026
Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched ComparatorsSissel Johanne Godtfredsen, Joachim Baech, Mikkel Porsborg Andersen, et al.
British Journal of Haematology|April 30, 2024
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort studyJulie Haugaard Vandtved, Andreas Kiesbye Øvlisen, Joachim Baech, et al.
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Pageof 4